Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  European Heart Journal

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/eurheartj/ehm258PMID 17098754
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy

  2011cited by this paper
• Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n−3 polyunsaturated fatty acids

  2006cited by this paper
• Bone-marrow-derived progenitor cell therapy in need of proof of concept: design of the REPAIR-AMI trial

  2006cited by this paper
• Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.

  2006influential reference
• Normalization of coronary blood flow in the infarct-related artery after intracoronary progenitor cell therapy:

  2006cited by this paper
• Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

  2006cited by this paper
• Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.

  2006cited by this paper
• Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction.

  2005cited by this paper
• Plasma triglyceride level is an independent predictor of altered left ventricular relaxation.

  2005cited by this paper
• Unchain my heart: the scientific foundations of cardiac repair.

  2005cited by this paper
• Experimental and Clinical Regenerative Capability of Human Bone Marrow Cells After Myocardial Infarction

  2004cited by this paper
• ransplantation of Progenitor Cells nd Regeneration Enhancement n Acute Myocardial Infarction

  2004cited by this paper
• Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial.

  2004cited by this paper
• Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.

  2004cited by this paper
• Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts

  2003cited by this paper
• Infarct Remodeling After Intracoronary Progenitor Cell Treatment in Patients With Acute Myocardial Infarction (TOPCARE-AMI): Mechanistic Insights From Serial Contrast-Enhanced Magnetic Resonance Imaging

  2003cited by this paper
• Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in Humans

  2002cited by this paper
• National diet and nutrition survey: young people aged 4 to 18 years

  2001cited by this paper
• Bone marrow cells regenerate infarcted myocardium

  2001cited by this paper
• Intracoronary Doppler– and Quantitative Coronary Angiography–Derived Predictors of Major Adverse Cardiac Events After Stent Implantation

  2001cited by this paper
• Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function

  2001cited by this paper
• Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial Ischemia

  2001cited by this paper
• Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs.

  2000cited by this paper
• Prognostic value of intracoronary flow velocity and diameter stenosis in assessing the short- and long-term outcomes of coronary balloon angioplasty: the DEBATE Study (Doppler Endpoints Balloon Angioplasty Trial Europe).

  1997cited by this paper
• Regression or progression. Dependency on vascular nitric oxide.

  1996cited by this paper
• Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit.

  1992cited by this paper
• Clinical Research Prevention and Epidemiology

  year unknowncited by this paper

• Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8)

  2025cites this paper
• Cardiomyocyte regeneration therapy and its effect on LVEF and scar size- a systematic review and meta-analysis

  2025cites this paper
• Myonectin stimulates endothelial angiogenic activity in vitro and in vivo

  2025cites this paper
• Stem cell therapy for patients with acute myocardial infarction: a systematic review of clinical trials

  2025cites this paper
• Resident vascular Sca1+ progenitors differentiate into endothelial cells in vascular remodeling via miR-145-5p/ERG signaling pathway

  2024cites this paper
• REGENERATE-COBRA: A Phase II randomized sham-controlled trial assessing the safety and efficacy of intracoronary administration of autologous bone marrow-derived cells in patients with refractory angina.

  2024cites this paper
• Emerging Strategies in Mesenchymal Stem Cell-Based Cardiovascular Therapeutics

  2024cites this paper
• Mid- to long-term efficacy and safety of stem cell therapy for acute myocardial infarction: a systematic review and meta-analysis

  2024cites this paper
• Multilineage contribution of CD34+ cells in cardiac remodeling after ischemia/reperfusion injury

  2023cites this paper
• Role of circulating CD14++CD16+ monocytes and VEGF-B186 in formation of collateral circulation in patients with hyperacute AMI

  2023cites this paper
• Healing the Ischaemic Heart: A Critical Review of Stem Cell Therapies

  2023cites this paper
• Tunable biomaterials for myocardial tissue regeneration: promising new strategies for advanced biointerface control and improved therapeutic outcomes.

  2022cites this paper
• In Vivo Cardiotoxic Potential of Micrurus frontalis Venom

  2022cites this paper
• Left Ventricular Remodeling after Myocardial Infarction: From Physiopathology to Treatment

  2022cites this paper
• Stem cell therapy for acute myocardial infarction - focusing on the comparison between Muse cells and mesenchymal stem cells.

  2021cites this paper
• Neovascularization: The Main Mechanism of MSCs in Ischemic Heart Disease Therapy

  2021cites this paper
• Impact of Diabetes Mellitus on the Potential of Autologous Stem Cells and Stem Cell–Derived Microvesicles to Repair the Ischemic Heart

  2021cites this paper
• Therapies to prevent post-infarction remodelling: From repair to regeneration.

  2021cites this paper
• Cell-Based Therapies for Heart Failure

  2021cites this paper
• Clinical-based Cell Therapies for Heart Disease—Current and Future State

  2020cites this paper
• Autologous CXCR4+ Hematopoietic Stem Cells Injected Into the Scar Tissue of Chronic Myocardial Infarction Patients Normalizes Tissue Contractility and Perfusion.

  2020cites this paper
• Stem Cell Therapy for Acute Myocardial Infarctions

  2020cites this paper
• ACE2/ACE imbalance and impaired vasoreparative functions of stem/progenitor cells in aging

  2020cites this paper
• Stem Cell Therapy for Chronic and Advanced Heart Failure

  2020cites this paper
• Evaluation of the effectiveness of infusion of bone marrow derived cell in patients with heart failure: A network meta-analysis of randomized clinical trials and cohort studies

  2020cites this paper
• SIRT3 Transfection of Aged Human Bone Marrow-Derived Mesenchymal Stem Cells Improves Cell Therapy-Mediated Myocardial Repair

  2020cites this paper
• Hypoxic regulation of angiotensin‐converting enzyme 2 and Mas receptor in human CD34+ cells

  2019cites this paper
• Injectable Supramolecular Ureidopyrimidinone Hydrogels Provide Sustained Release of Extracellular Vesicle Therapeutics

  2019cites this paper
• Application of Bioengineered Materials in the Surgical Management of Heart Failure

  2019cites this paper
• G-CSF for Extensive STEMI: Results from the STEM-AMI OUTCOME CMR Substudy.

  2019cites this paper
• Optimization of Timing and Times for Administration of Atorvastatin‐Pretreated Mesenchymal Stem Cells in a Preclinical Model of Acute Myocardial Infarction

  2019cites this paper
• 3D printing approaches for cardiac tissue engineering and role of immune modulation in tissue regeneration

  2019cites this paper
• Cardiac fibrosis: potential therapeutic targets.

  2019cites this paper
• Intramyocardial bone marrow cell injection does not lead to functional improvement in patients with chronic ischaemic heart failure without considerable ischaemia

  2018cites this paper
• Cell therapy for heart disease after 15 years: Unmet expectations

  2018cites this paper
• Myocardial regeneration therapy in heart failure: Current status and future therapeutic implications in clinical practice.

  2018cites this paper
• Recent Advances in Treatment of Coronary Artery Disease: Role of Science and Technology

  2018cites this paper
• Recent treatment modalities for cardiovascular diseases with a focus on stem cells, aptamers, exosomes and nanomedicine

  2018cites this paper
• Cardiac mesenchymal cells from diabetic mice are ineffective for cell therapy-mediated myocardial repair

  2018cites this paper
• Gene therapy with the angiogenic neuropeptide secretoneurin ameliorates experimental diabetic neuropathy

  2018cites this paper
• The role of stem cells in treating coronary artery disease in 2018

  2018cites this paper
• Cell-Based Therapies for Cardiac Regeneration: A Comprehensive Review of Past and Ongoing Strategies

  2018cites this paper
• Sirtuin3 protects aged human mesenchymal stem cells against oxidative stress and enhances efficacy of cell therapy for ischaemic heart diseases

  2018cites this paper
• Angiogenic lncRNAs: A potential therapeutic target for ischaemic heart disease

  2018cites this paper
• The current status of stem cell therapy in ischemic heart disease

  2018cites this paper
• Predictive Value of Circulating Progenitor Cells in Acute Coronary Syndrome: Implications for Treatment.

  2018cites this paper
• Clinical Studies of Cell Therapy in Cardiovascular Medicine: Recent Developments and Future Directions

  2018cites this paper
• Emerging Therapies for Congestive Heart Failure

  2018cites this paper
• Active Stromal Cell–Derived Factor 1α and Endothelial Progenitor Cells are Equally Increased by Alogliptin in Good and Poor Diabetes Control

  2017cites this paper
• Intracoronary autologous bone marrow cell transfer after acute myocardial infarction: abort and refocus

  2017cites this paper
• Cell Therapies in Cardiomyopathy: Current Status of Clinical Trials

  2017cites this paper
• Bone marrow cells for heart repair: clinical evidence and perspectives.

  2017cites this paper
• Cortical Bone Stem Cell Therapy Preserves Cardiac Structure and Function After Myocardial Infarction

  2017cites this paper
• Contractile force generation by 3D hiPSC-derived cardiac tissues is enhanced by rapid establishment of cellular interconnection in matrix with muscle-mimicking stiffness.

  2017cites this paper
• Stem cell therapy for ischemic heart diseases.

  2017cites this paper
• Platelet-Targeted Delivery of Peripheral Blood Mononuclear Cells to the Ischemic Heart Restores Cardiac Function after Ischemia-Reperfusion Injury

  2017cites this paper
• Bone marrow-derived cells and their conditioned medium induce microvascular repair in uremic rats by stimulation of endogenous repair mechanisms

  2017cites this paper
• Stem cell therapies for myocardial infarction in clinical trials: bioengineering and biomaterial aspects

  2017cites this paper
• Progenitor Cells for Arterial Repair: Incremental Advancements towards Therapeutic Reality

  2017cites this paper
• Regeneration of full-thickness skin defects by differentiated adipose-derived stem cells into fibroblast-like cells by fibroblast-conditioned medium

  2017cites this paper
• Translational cardiac stem cell therapy: advancing from first-generation to next-generation cell types

  2017cites this paper
• Characteristics and Cardiomyogenic Potential of Rat Fetal Cardiac Progenitor Cells at Different Developmental Stage

  2017cites this paper
• The effect of intracoronary infusion of bone marrow‐derived mononuclear cells on all‐cause mortality in acute myocardial infarction: rationale and design of the BAMI trial

  2017cites this paper
• Cardiomyocyte renewal in the human heart: insights from the fall-out

  2017cites this paper
• Injectable Bioengineered Hydrogel Therapy in the Treatment of Ischemic Cardiomyopathy

  2017cites this paper
• Novel molecular targets for coronary angiogenesis and ischemic heart disease

  2017cites this paper
• Cellular Therapy for Heart Failure

  2016cites this paper
• Angiogenic Effects of Dimeric Dipeptide Mimetic of Loop 4 of Nerve Growth Factor

  2016cites this paper
• Pathophysiology of ST-segment elevation myocardial infarction: novel mechanisms and treatments.

  2016cites this paper
• Recent Developments in Stem and Progenitor Cell Therapy for Cardiac Repair.

  2016cites this paper
• Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure.

  2016cites this paper
• Hypoxia-preconditioned allogeneic mesenchymal stem cells can be used for myocardial repair in non-human primates.

  2016cites this paper
• Type 2 Diabetes Dysregulates Glucose Metabolism in Cardiac Progenitor Cells*

  2016cites this paper
• Angio-Vasculogenic Properties of Endothelial-Induced Mesenchymal Stem Cells Derived From Human Adipose Tissue.

  2016cites this paper
• Discrepancy between short-term and long-term effects of bone marrow-derived cell therapy in acute myocardial infarction: a systematic review and meta-analysis

  2016cites this paper
• Lysophosphatidic acid enhances survival of human CD34+ cells in ischemic conditions

  2015cites this paper
• Stem cell therapy for cardiovascular diseases: a progressive journey

  2015cites this paper
• HGF and IGF‐1 promote protective effects of allogeneic BMSC transplantation in rabbit model of acute myocardial infarction

  2015cites this paper
• Investigational new drugs for the treatment of acute coronary syndrome

  2015cites this paper
• Intravenous Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke: Phase1/2a Clinical Trial in a Homogeneous Group of Stroke Patients

  2015cites this paper
• Xenotransplantation of Human Cardiomyocyte Progenitor Cells Does Not Improve Cardiac Function in a Porcine Model of Chronic Ischemic Heart Failure. Results from a Randomized, Blinded, Placebo Controlled Trial

  2015cites this paper
• Stem cell therapy for heart failure: Out with the new and in with the old?

  2015cites this paper
• Recent advances in the diagnosis and treatment of acute myocardial infarction.

  2015cites this paper
• Gene expression profiling of CD133-positive cells in coronary artery disease.

  2015cites this paper
• Stem cells in the management of heart failure: what have we learned from clinical trials?

  2015cites this paper
• Immuno-modification of enhancing stem cells targeting for myocardial repair

  2015cites this paper
• Assessment of bone marrow-derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trial

  2015cites this paper
• The Clinical Status of Stem Cell Therapy for Ischemic Cardiomyopathy

  2015cites this paper
• Adult Bone Marrow Cell Therapy for Ischemic Heart Disease: Evidence and Insights From Randomized Controlled Trials.

  2015cites this paper
• The role of coronary microvascular disorder in congestive heart failure.

  2015cites this paper
• Efficacy of stem cell in improvement of left ventricular function in acute myocardial infarction - MI3 Trial

  2015cites this paper
• Enhanced Cardiac Regenerative Ability of Stem Cells After Ischemia-Reperfusion Injury: Role of Human CD34+ Cells Deficient in MicroRNA-377.

  2015cites this paper
• Rapid assay of stem cell functionality and potency using electric cell-substrate impedance sensing

  2015cites this paper
• Prostaglandin E1 protects bone marrow-derived mesenchymal stem cells against serum deprivation-induced apoptosis

  2015cites this paper
• Timing for intracoronary administration of bone marrow mononuclear cells after acute ST-elevation myocardial infarction: a pilot study

  2015cites this paper
• Generating patient-specific induced pluripotent stem cells-derived cardiomyocytes for the treatment of cardiac diseases

  2015cites this paper
• Stem cell treatment for acute myocardial infarction.

  2015cites this paper
• Autologous c‐Kit+ Mesenchymal Stem Cell Injections Provide Superior Therapeutic Benefit as Compared to c‐Kit+ Cardiac‐Derived Stem Cells in a Feline Model of Isoproterenol‐Induced Cardiomyopathy

  2015cites this paper
• Melatonin protects ADSCs from ROS and enhances their therapeutic potency in a rat model of myocardial infarction

  2015cites this paper
• Improved Proliferation and Differentiation of Bone Marrow Mesenchymal Stem Cells Into Vascular Endothelial Cells With Sphingosine 1-Phosphate.

  2015cites this paper